Acceptance of Mass Drug Administration for Prophylaxis against Lymphatic Filariasis in a Tribal Endemic Area: A Descriptive Cross-sectional Study
Background: India is at a critical stage to eliminate filariasis. Uncovering the factors governing may help taking appropriate measures to achieve the goal. Objectives: This study evaluated the acceptance of “mass drug administration” (MDA) for prophylaxis against filariasis and the factors facilita...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2024-04-01
|
| Series: | Indian Journal of Public Health |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/ijph.ijph_312_23 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832586791963590656 |
|---|---|
| author | Asmit Agarwal Vikas Maharshi |
| author_facet | Asmit Agarwal Vikas Maharshi |
| author_sort | Asmit Agarwal |
| collection | DOAJ |
| description | Background:
India is at a critical stage to eliminate filariasis. Uncovering the factors governing may help taking appropriate measures to achieve the goal.
Objectives:
This study evaluated the acceptance of “mass drug administration” (MDA) for prophylaxis against filariasis and the factors facilitating and interfering with it.
Materials and Methods:
A cross-sectional study was conducted in a tribal endemic area of India from May 2022 to October 2022. A validated 29-item self-administered questionnaire was used to collect the data. Items were grouped under “knowledge,” “social processes,” “think and feel,” “practical factors,” and “motivation/hesitancy” domains.
Results:
Of 101 participants, majority were aware of the disease (92.1%), its vector (74.3%), at least one disability caused (87.2%), and governmental scheme of MDA (69.3%). Two-thirds never received and 85.1% did not receive MDA within 1 year. 68.3% refused of distribution of MDA to their doorstep. Majority were concerned for getting MDA for self and their family/friends; however, 49.5% showed inability to take independent decision. More than 30% disagreed to get MDA had it been available. The region with the highest concerns for adverse drug effects showed minimum MDA consumption than others (P < 0.05). MDA acceptance/consumption was significantly associated with knowledge about disability caused, distribution of drugs by a health-care representative to doorstep, behavior of the representative, and concerns about potential adverse drug effects.
Conclusion:
MDA coverage was inadequate in the study population. Level of knowledge, practical difficulties in getting drugs, inapt thinking/concerns, motivation, awareness about disabilities caused, door-to-door drug distribution, and behavior of health-care representative(s), were identified as factors significantly affecting acceptance of MDA. |
| format | Article |
| id | doaj-art-65cd8463061d45d69483d139657af26e |
| institution | Kabale University |
| issn | 0019-557X 2229-7693 |
| language | English |
| publishDate | 2024-04-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | Indian Journal of Public Health |
| spelling | doaj-art-65cd8463061d45d69483d139657af26e2025-01-25T05:15:52ZengWolters Kluwer Medknow PublicationsIndian Journal of Public Health0019-557X2229-76932024-04-0168219420010.4103/ijph.ijph_312_23Acceptance of Mass Drug Administration for Prophylaxis against Lymphatic Filariasis in a Tribal Endemic Area: A Descriptive Cross-sectional StudyAsmit AgarwalVikas MaharshiBackground: India is at a critical stage to eliminate filariasis. Uncovering the factors governing may help taking appropriate measures to achieve the goal. Objectives: This study evaluated the acceptance of “mass drug administration” (MDA) for prophylaxis against filariasis and the factors facilitating and interfering with it. Materials and Methods: A cross-sectional study was conducted in a tribal endemic area of India from May 2022 to October 2022. A validated 29-item self-administered questionnaire was used to collect the data. Items were grouped under “knowledge,” “social processes,” “think and feel,” “practical factors,” and “motivation/hesitancy” domains. Results: Of 101 participants, majority were aware of the disease (92.1%), its vector (74.3%), at least one disability caused (87.2%), and governmental scheme of MDA (69.3%). Two-thirds never received and 85.1% did not receive MDA within 1 year. 68.3% refused of distribution of MDA to their doorstep. Majority were concerned for getting MDA for self and their family/friends; however, 49.5% showed inability to take independent decision. More than 30% disagreed to get MDA had it been available. The region with the highest concerns for adverse drug effects showed minimum MDA consumption than others (P < 0.05). MDA acceptance/consumption was significantly associated with knowledge about disability caused, distribution of drugs by a health-care representative to doorstep, behavior of the representative, and concerns about potential adverse drug effects. Conclusion: MDA coverage was inadequate in the study population. Level of knowledge, practical difficulties in getting drugs, inapt thinking/concerns, motivation, awareness about disabilities caused, door-to-door drug distribution, and behavior of health-care representative(s), were identified as factors significantly affecting acceptance of MDA.https://journals.lww.com/10.4103/ijph.ijph_312_23acceptanceeliminationfilariasismass drug administrationmotivationquestionnaire |
| spellingShingle | Asmit Agarwal Vikas Maharshi Acceptance of Mass Drug Administration for Prophylaxis against Lymphatic Filariasis in a Tribal Endemic Area: A Descriptive Cross-sectional Study Indian Journal of Public Health acceptance elimination filariasis mass drug administration motivation questionnaire |
| title | Acceptance of Mass Drug Administration for Prophylaxis against Lymphatic Filariasis in a Tribal Endemic Area: A Descriptive Cross-sectional Study |
| title_full | Acceptance of Mass Drug Administration for Prophylaxis against Lymphatic Filariasis in a Tribal Endemic Area: A Descriptive Cross-sectional Study |
| title_fullStr | Acceptance of Mass Drug Administration for Prophylaxis against Lymphatic Filariasis in a Tribal Endemic Area: A Descriptive Cross-sectional Study |
| title_full_unstemmed | Acceptance of Mass Drug Administration for Prophylaxis against Lymphatic Filariasis in a Tribal Endemic Area: A Descriptive Cross-sectional Study |
| title_short | Acceptance of Mass Drug Administration for Prophylaxis against Lymphatic Filariasis in a Tribal Endemic Area: A Descriptive Cross-sectional Study |
| title_sort | acceptance of mass drug administration for prophylaxis against lymphatic filariasis in a tribal endemic area a descriptive cross sectional study |
| topic | acceptance elimination filariasis mass drug administration motivation questionnaire |
| url | https://journals.lww.com/10.4103/ijph.ijph_312_23 |
| work_keys_str_mv | AT asmitagarwal acceptanceofmassdrugadministrationforprophylaxisagainstlymphaticfilariasisinatribalendemicareaadescriptivecrosssectionalstudy AT vikasmaharshi acceptanceofmassdrugadministrationforprophylaxisagainstlymphaticfilariasisinatribalendemicareaadescriptivecrosssectionalstudy |